| Issue date | Patent Title | Patent No. |
| 2023/1/5 | 5-methoxytryptophan and its derivatives and uses thereof | NZ733731 |
| 2023/1/10 | Dipicolylamine derivatives and their pharmaceutical uses | CA2949663 |
| 2023/1/13 | Anti-Aβ antibodies and uses thereof | JP7210612 |
| 2023/1/24 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | CA3109623 |
| 2023/1/27 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | HK40053325 |
| 2023/2/10 | Heterocyclic compounds and use thereof | IN421151 |
| 2023/2/11 | Method of removing motion-induced ghost artifacts in MRI | TWI792513 |
| 2023/2/11 | Storage media for preservation of corneal tissue | TWI792427 |
| 2023/3/1 | PTGR2 inhibitors and their use | TWI795232 |
| 2023/3/3 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | IN424040 |
| 2023/3/8 | Heterocyclic compounds and use thereof | KR10-2509431 |
| 2023/3/14 | Method of Producing Exosomes from Stem Cells and Use Thereof | JP7244988 |
| 2023/3/21 | Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine | CA3025484 |
| 2023/3/21 | Aminothiazole compounds as protein kinase inhibitors | CA3064081 |
| 2023/3/30 | Dual-function antibodies targeting VEGFR2 and VEGFR3 | AU2019239984 |
| 2023/4/11 | Anti-RSPO3 antibodies | US11623951 |
| 2023/4/11 | Dual-Function Antibodies Targeting VEGFR2 and VEGFR3 | US11623960 |
| 2023/4/13 | Anti-Aβ antibodies and uses thereof | KR10-2523019 |
| 2023/4/21 | Poly heterocyclic drug conjugates and their pharmaceutical uses | TWI799896 |
| 2023/5/1 | Focused Ultrasound Device and Methods for Dermatological Treatments | TWI800656 |